In conclusion, we have shown for the first time that BCL-3 potentiates β-catenin/TCF-mediated signalling in CRC, and selectively regulates transcription of intestinal stem cell genes and Wnt targets LGR5 and ASCL2, promoting a CSC phenotype. The gene discussed is ASCL2; the disease is colorectal carcinoma.